Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $7.73 Million - $13.7 Million
-350,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $3.17 Million - $4.78 Million
-159,191 Reduced 31.26%
350,000 $8.8 Million
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $7.75 Million - $18.5 Million
-640,809 Reduced 55.72%
509,191 $14.7 Million
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $9.12 Million - $18.2 Million
1,150,000 New
1,150,000 $14.1 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.34B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track 12 West Capital Management LP Portfolio

Follow 12 West Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on 12 West Capital Management LP with notifications on news.